Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Pharmaceutical composition for angiocardiography and preparation method thereof

A cardiovascular and composition technology, which is applied in the field of postoperative adjuvant therapy for cardiac function examination, can solve the problems of insufficient vitality of patients, slow recovery of trauma sites, and unfavorable recovery.

Inactive Publication Date: 2017-11-10
QINGDAO CENT HOSPITAL
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The technical problem solved by the present invention is that after angiographic examination, the patient's own vitality is insufficient, the wound site recovers slowly and is susceptible to infection, which adds a lot of pain to the patient, and after the contrast agent is injected, some patients will have some mild symptoms. Reactions such as nausea, vomiting, skin itching and rash, etc., are not conducive to later recovery

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0055] A pharmaceutical composition for cardiovascular angiography, which is composed of the following components in parts by mass for oral administration: 5 parts of fried Atractylodes macrocephala, 5 parts of longan, 4 parts of Gynostemma pentaphyllum, 4 parts of Shichancao, 1 part of Anemarrhena, 5 parts of Angelica, 4 parts of Scutellaria barbata, 4 parts of Dingcao root, 2 parts of safflower, 4 parts of blue calyx fragrant tea, 4 parts of Shi Jianchuan, 5 parts of rhodiola rosea, 5 parts of licorice, 4 parts of eight treasure tea, 5 parts of cinnamon bark, 4 parts of ginkgo fruit and 4 parts of paeonol; the medicine for external use is composed of the following components in mass parts: 5 parts of Radix Radix, 4 parts of calamine, 5 parts of Hedyotis diffusa, 4 parts of S. chinensis, 5 parts of Burnet, 7 parts of soybeans, 1 part of menthol, 4 parts of thyme, and 4 parts of Houttuynia cordata.

[0056] Wherein the preparation method of oral medicine consists of the follow...

Embodiment 2

[0068] A pharmaceutical composition for cardiovascular angiography, which is composed of the following components in parts by mass for oral administration: 6 parts of fried Atractylodes macrocephala, 4 parts of longan, 5 parts of Gynostemma pentaphyllum, 3 parts of Shichancao, 2 parts of Anemarrhena, 4 parts of angelica, 5 parts of Scutellaria barbata, 3 parts of Dingcao root, 2 parts of safflower, 3 parts of blue calyx fragrant tea, 5 parts of Shi Jianchuan, 4 parts of rhodiola rosea, 6 parts of licorice, 3 parts of eight treasure tea, 6 parts of cinnamon bark, 3 parts of ginkgo, 5 parts of paeonol; the external medicine is composed of the following components in parts by mass: 4 parts of Radix Radix, 5 parts of calamine, 4 parts of Hedyotis diffusa, 5 parts of Paeonia, 4 parts of Burnet, 8 parts of soybeans, 1 part of menthol, 5 parts of thyme, 3 parts of Houttuynia cordata.

[0069] Wherein the preparation method of oral medicine consists of the following steps:

[0070] (...

Embodiment 3

[0081] A pharmaceutical composition for cardiovascular angiography, which is composed of the following components in parts by mass for oral administration: 4 parts of fried Atractylodes macrocephala, 6 parts of longan, 3 parts of Gynostemma pentaphyllum, 5 parts of Shichancao, 1 part of Anemarrhena, 6 parts of angelica, 3 parts of Scutellaria barbata, 5 parts of Dingcao root, 1 part of safflower, 5 parts of blue calyx fragrant tea, 3 parts of Shi Jianchuan, 6 parts of Rhodiola rosea, 4 parts of licorice, 5 parts of Babao tea, 4 parts of cinnamon bark, 5 parts of ginkgo fruit and 3 parts of paeonol; the medicine for external use is composed of the following components in parts by mass: 6 parts of Radix Radix, 3 parts of calamine, 6 parts of Hedyotis diffusa, 3 parts of Paeonia chinensis, 6 parts of Burnet, 5 parts of soybean, 2 parts of menthol, 3 parts of thyme, 5 parts of Houttuynia cordata.

[0082] Wherein the preparation method of oral medicine consists of the following st...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of adjuvant therapy after heart function examination, and in particular relates to a pharmaceutical composition for cardiovascular angiography and a preparation method thereof. Wherein the medicine for internal use is composed of the following components by mass: 4-6 parts of fried Atractylodes macrocephala, 4-6 parts of longan, 3-5 parts of Gynostemma pentaphyllum, 3-5 parts of Shichancao, 1-2 parts of Anemarrhena anemarrhenae, 4-6 parts of angelica 6 parts, 3‑5 parts of Scutellaria barbata, 3‑5 parts of Dingcaogen, 1‑2 parts of safflower, 3‑5 parts of blue calyx, 3‑5 parts of Shi Jianchuan, 4‑6 parts of Rhodiola rosea , 4-6 parts of licorice, 3-5 parts of Babao tea, 4-6 parts of cassia bark, 3-5 parts of ginkgo, 3-5 parts of paeonol; the medicine for external use is composed of the following components by mass: Radix Radix 4-6 3-5 parts of Calamine, 4-6 parts of Hedyotis diffusa, 3-5 parts of Saulberry, 4-6 parts of Burnet, 5-8 parts of Soybean, 1-2 parts of Menthol, 3 parts of Thyme ‑5 parts, Houttuynia cordata 3‑5 parts. The invention uses oral Chinese medicinal preparations for treatment, and at the same time utilizes wounds caused by inspections to introduce medicinal liquids to promote wound healing, which is beneficial to disease recovery and achieves good curative effect.

Description

technical field [0001] The invention belongs to the technical field of adjuvant therapy after heart function examination, and in particular relates to a pharmaceutical composition for cardiovascular angiography and a preparation method thereof. Background technique [0002] Cardiac function room refers to the medical room specially used to test the heart function in the hospital, which generally stores some heart function test instruments, mainly to check the following aspects of heart function: 1. Dynamic electrocardiogram, 2. Exercise electrocardiogram, 3. Esophagus Pacing, 4. Ventricular late potential, 5. Vector cardiogram, 6. Heart function test. It is an examination department that measures the systolic function, diastolic function, blood pumping function and autonomic nerve regulation function of the heart through various inspection methods. Cardiac function tests are specifically divided into two categories: invasive and non-invasive. Invasive tests include cardiac ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8964A61K36/78A61K9/48A61K9/08A61P9/10A61P9/00A61P17/02A61P31/02A61P31/04A61P31/10A61K31/045A61K33/30
CPCA61K36/284A61K9/0014A61K9/08A61K9/4808A61K9/4858A61K31/045A61K33/30A61K36/12A61K36/16A61K36/195A61K36/232A61K36/286A61K36/315A61K36/37A61K36/41A61K36/424A61K36/48A61K36/484A61K36/53A61K36/537A61K36/539A61K36/54A61K36/65A61K36/67A61K36/71A61K36/739A61K36/748A61K36/77A61K36/78A61K36/8964A61K2236/15A61K2236/17A61K2236/331A61K2236/39A61K2236/51A61K2236/53
Inventor 于婧于筱水柳洋刘广焕
Owner QINGDAO CENT HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products